Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9247 USD | +7.94% |
|
-8.45% | -25.43% |
06-24 | Akebia Therapeutics Names Erik Ostrowski CFO, CBO | MT |
06-24 | Akebia Therapeutics, Inc. Appoints Erik Ostrowski as Senior Vice President and Chief Business Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.43% | 194M | |
+16.49% | 122B | |
+21.73% | 115B | |
+22.07% | 26.64B | |
-21.81% | 19.91B | |
-16.89% | 16.32B | |
-18.81% | 15.49B | |
-44.74% | 15.52B | |
+62.72% | 14.83B | |
+3.09% | 13.67B |
- Stock Market
- Equities
- AKBA Stock
- News Akebia Therapeutics, Inc.
- Akebia Therapeutics Names Nicholas Grund as Chief Commercial Officer